179 related articles for article (PubMed ID: 17875713)
1. Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-AP-1 induced cell transformation.
Yao K; Cho YY; Bergen HR; Madden BJ; Choi BY; Ma WY; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(18):8725-35. PubMed ID: 17875713
[TBL] [Abstract][Full Text] [Related]
2. c-Jun NH2-terminal kinase 2 is required for Ras transformation independently of activator protein 1.
Nielsen C; Thastrup J; Bøttzauw T; Jäättelä M; Kallunki T
Cancer Res; 2007 Jan; 67(1):178-85. PubMed ID: 17210697
[TBL] [Abstract][Full Text] [Related]
3. A JNK1/AP-1-dependent, COX-2 induction is implicated in 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation through regulating cell cycle progression.
Zhang D; Li J; Song L; Ouyang W; Gao J; Huang C
Mol Cancer Res; 2008 Jan; 6(1):165-74. PubMed ID: 18234971
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
5. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate.
She QB; Chen N; Bode AM; Flavell RA; Dong Z
Cancer Res; 2002 Mar; 62(5):1343-8. PubMed ID: 11888903
[TBL] [Abstract][Full Text] [Related]
7. T-lymphokine-activated killer cell-originated protein kinase functions as a positive regulator of c-Jun-NH2-kinase 1 signaling and H-Ras-induced cell transformation.
Oh SM; Zhu F; Cho YY; Lee KW; Kang BS; Kim HG; Zykova T; Bode AM; Dong Z
Cancer Res; 2007 Jun; 67(11):5186-94. PubMed ID: 17545598
[TBL] [Abstract][Full Text] [Related]
8. [ERK and JNK/AP-1 pathways involved in benzo(a)pyrene induced cell cycle changes in human embryo lung fibroblasts].
Gao A; Liu BC; Huang CS; Shi XL; Jia XW; You BR; Ye M
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Feb; 24(2):72-6. PubMed ID: 16600107
[TBL] [Abstract][Full Text] [Related]
9. Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.
She QB; Ma WY; Dong Z
Oncogene; 2002 Feb; 21(10):1580-9. PubMed ID: 11896587
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
Oleinik NV; Krupenko NI; Krupenko SA
Oncogene; 2007 Nov; 26(51):7222-30. PubMed ID: 17525747
[TBL] [Abstract][Full Text] [Related]
11. Direct evidence for the critical role of NFAT3 in benzo[a]pyrene diol-epoxide-induced cell transformation through mediation of inflammatory cytokine TNF induction in mouse epidermal Cl41 cells.
Ouyang W; Hu Y; Li J; Ding M; Lu Y; Zhang D; Yan Y; Song L; Qu Q; Desai D; Amin S; Huang C
Carcinogenesis; 2007 Oct; 28(10):2218-26. PubMed ID: 17522069
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression profiles of Jnk1- and Jnk2-deficient murine fibroblast cells.
Chen N; She QB; Bode AM; Dong Z
Cancer Res; 2002 Mar; 62(5):1300-4. PubMed ID: 11888895
[TBL] [Abstract][Full Text] [Related]
13. SAPKgamma/JNK1 and SAPKalpha/JNK2 mRNA transcripts are expressed in early gestation human placenta and mouse eggs, preimplantation embryos, and trophoblast stem cells.
Zhong W; Sun T; Wang QT; Wang Y; Xie Y; Johnson A; Leach R; Puscheck EE; Rappolee DA
Fertil Steril; 2004 Oct; 82 Suppl 3():1140-8. PubMed ID: 15474087
[TBL] [Abstract][Full Text] [Related]
14. JNK1, but not JNK2, is required for COX-2 induction by nickel compounds.
Zhang D; Li J; Wu K; Ouyang W; Ding J; Liu ZG; Costa M; Huang C
Carcinogenesis; 2007 Apr; 28(4):883-91. PubMed ID: 17065197
[TBL] [Abstract][Full Text] [Related]
15. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
Katagiri C; Negishi K; Hibino T
J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
[TBL] [Abstract][Full Text] [Related]
16. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice.
Chen N; Nomura M; She QB; Ma WY; Bode AM; Wang L; Flavell RA; Dong Z
Cancer Res; 2001 May; 61(10):3908-12. PubMed ID: 11358804
[TBL] [Abstract][Full Text] [Related]
17. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
Ma FY; Flanc RS; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
J Am Soc Nephrol; 2007 Feb; 18(2):472-84. PubMed ID: 17202416
[TBL] [Abstract][Full Text] [Related]
18. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
19. Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation.
Mathiasen DP; Egebjerg C; Andersen SH; Rafn B; Puustinen P; Khanna A; Daugaard M; Valo E; Tuomela S; Bøttzauw T; Nielsen CF; Willumsen BM; Hautaniemi S; Lahesmaa R; Westermarck J; Jäättelä M; Kallunki T
Oncogene; 2012 Jan; 31(3):390-401. PubMed ID: 21706057
[TBL] [Abstract][Full Text] [Related]
20. IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.
Lin CC; Kuo CT; Cheng CY; Wu CY; Lee CW; Hsieh HL; Lee IT; Yang CM
Cell Signal; 2009 Nov; 21(11):1652-62. PubMed ID: 19616091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
